HEMORR₂HAGES
Bleeding risk assessment in patients with atrial fibrillation receiving anticoagulants.
Liver or kidney disease
Alcohol abuse
History of malignancy
Age
Reduced platelet count and function (aspirin use, thrombocytopenia, hematologic disorders: thrombophilia, etc.)
Uncontrolled arterial hypertension
Prior bleeding episode in history
Anemia (hemoglobin <130 g/L for men, <120 g/L for women)
High risk of falls, dementia, Parkinson's disease, or mental disorders
Genetic factors (single nucleotide polymorphisms CYP2C9)
History of stroke